# Evaluation of Efficacy and Tolerability of Hizentra®

> **NCT01354587** · NA · UNKNOWN · sponsor: **University of South Florida** · enrollment: 50 (estimated)

## Conditions studied

- Primary Immunodeficiency Disorders

## Interventions

- **DRUG:** Hizentra

## Key facts

- **NCT ID:** NCT01354587
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2012-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01354587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01354587, "Evaluation of Efficacy and Tolerability of Hizentra®". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01354587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*